Group One Trading
AEGR

Group One Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Group One Trading’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,362
Closed -$24.9K – 5245
2016
Q2 		$21K Buy
+14,362
New +$32.9K ﹤0.01% 3789
2016
Q1 		– Sell
-51,875
Closed -$321K – 5343
2015
Q4 		$524K Buy
51,875
+4,550
+10% +$54.8K 0.01% 1788
2015
Q3 		$644K Buy
47,325
+27,945
+144% +$498K 0.01% 1577
2015
Q2 		$368K Sell
19,380
-42,350
-69% -$917K 0.01% 2048
2015
Q1 		$1.61M Sell
61,730
-47,885
-44% -$1.22M 0.03% 764
2014
Q4 		$2.29M Buy
109,615
+7,656
+8% +$193K 0.03% 581
2014
Q3 		$3.4M Sell
101,959
-9,123
-8% -$283K 0.05% 432
2014
Q2 		$3.56M Buy
+111,082
New +$4.14M 0.05% 406
2013
Q4 		– Sell
-26,679
Closed -$2.04M – 5773
2013
Q3 		$2.29M Sell
26,679
-38,223
-59% -$3.24M 0.04% 489
2013
Q2 		$4.11M Buy
+64,902
New +$3.45M 0.1% 188

Group One Trading's AEGR Position: Q3 2016 in Review

Group One Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2016, closing a stake of 14,362 shares — an estimated $24.9K sold.

Group One Trading first reported a position in AEGR in Q2 2013 and held it in 10 quarters. The position peaked at $4.11M in Q2 2013. 58 funds tracked by Wall St. Rank hold AEGR as of Q3 2016.

  • Group One Trading reported no remaining Aegerion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Group One Trading sold 14,362 Aegerion Pharmaceuticals shares in Q3 2016, an estimated $24.9K.
  • Group One Trading first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Aegerion Pharmaceuticals position peaked at $4.11M in Q2 2013.
  • 58 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2016.

Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.